IQVIA Holdings | IQV - Current Liabilities


IQVIA Holdings reported $8.33B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Accenture USD 21.61B 651.67M Mar/2026
Agilent USD 2.27B 35M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Cardinal Health USD 41.99B 1.33B Mar/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cigna USD 52.61B 3.74B Mar/2026
Cognizant Technology Solutions USD 3.52B 139M Mar/2026
Computer Programs Systems USD 57.96M 4.21M Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
CVS Health USD 86.41B 2.29B Mar/2026
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.21B 136M Mar/2026
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Elevance Health USD 45.31B 4.27B Mar/2026
Humana USD 21.51B 5.16B Mar/2026
IBM USD 40.1B 1.44B Mar/2026
Illumina USD 1.57B 19M Mar/2026
Infosys INR 499.34B 35.36B Dec/2025
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Laboratory Of America USD 2.64B 182.5M Mar/2026
Malin Corporation EUR 1000K 500K Dec/2024
McKesson USD 67.02B 1.11B Mar/2026
Mettler Toledo International USD 1.11B 89.76M Mar/2026
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 186K 2.26M Jun/2025
Pharma Mar EUR 89.23M 4.65M Mar/2026
Publicis EUR 23.89B 3.02B Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Quest Diagnostics USD 2.18B 101M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
UnitedHealth USD 114.12B 773M Mar/2026
Veeva Systems USD 1.7B 64.71M Mar/2026
Veradigm USD 230.31M 22.78M Dec/2022
Waters USD 1.24B 11.8M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026